Cyclerion

A struggling biotech wraps its main assets into a new drug company
BioPharma Dive
Mon, 05/15/23 - 10:01 am
Cyclerion
M&A
Hard pressed for cash, Cyclerion looks for help funding rare disease drug
Endpoints
Fri, 03/24/23 - 10:04 am
Cyclerion
clinical trials
MELAS
zagociguat
BioSpace Layoff Tracker 2022: Cyclerion, OncoSec Implement Restructuring Initiatives
BioSpace
Fri, 10/7/22 - 10:45 am
layoffs
Cyclerion
OncoSec
Exicure
AbbVie
Bristol Myers Squibb
Palisade Bio
ObsEva
Rubius Therapeutics
Novartis
Finch Therapeutics
Ironwood's former pipeline spinout hits another speed bump, laying off 45% and turning toward the mitochondria
Endpoints
Thu, 10/6/22 - 10:57 am
Cyclerion
Ironwood
layoffs
mitochondrial disorders
Cyclerion fails sickle cell test, prompting pivot to CNS disease
Fierce Biotech
Wed, 10/14/20 - 10:46 am
Cyclerion
olinciguat
sickle cell disease
CNS
IW-6463
With 2 Failed Trials, Cyclerion Announces Plans to Cut 30 Out of 135 Jobs
BioSpace
Wed, 10/30/19 - 11:04 pm
Cyclerion
clinical trials
praliciguat
diabetic neuropathy
layoffs
Ironwood Pharma Spins off Cyclerion Therapeutics With 5 Orphan Disease Compounds
BioSpace
Tue, 04/2/19 - 12:02 pm
Ironwood Pharmaceuticals
Cyclerion
spinoffs
orphan diseases
Ironwood spinout Cyclerion planning $175M private placement
BioCentury
Tue, 02/26/19 - 11:52 pm
Cyclerion
Ironwood Pharmaceuticals
Ironwood to cut 35 more jobs as company split nears
BioPharma Dive
Wed, 02/13/19 - 04:52 pm
Ironwood Pharmaceuticals
layoffs
spinoffs
Cyclerion